Mary Greeley Cancer Case Conference

Ames, IA US
March 8, 2024


A multidisciplinary clinical activity that maintains, develops, or increases the knowledge, skills, professional performance, and relationships that a physician uses to provide services for patients, the public, or the profession.  

Target Audience

Limited to MGMC-approved providers, referring physicians, and other health care providers who practice and/or refer patients for care at Mary Greeley Medical Center.

Learning Objectives

Following the conference, participants should have an enhanced understanding of our diagnostic procedures and treatment planning for patients with the following types of cancer: Invasive Ductal Carcinoma, Nodular Malignant Melanoma, Adenocarcinoma, Follicular Neoplasm, Diffuse Large B-Cell Lymphoma.


Christopher Johnson, MD
Pathologist, McFarland Clinic, Ames, IA


  • American Board of Pathology
  • Anatomic and Clinical Pathology
  • Cytopathology


  • MD: University of Iowa Hospitals & Clinics, Iowa City, IA
  • Residency: University of Iowa Hospitals & Clinics, Iowa City, IA
  • Fellowship: University of Iowa Hospitals & Clinics, Iowa City, IA
    • Surgical Pathology
    • Cytopathology
Course summary
Available credit: 
  • 1.00 AOA Category 2­A
Course opens: 
Course expires: 
Event starts: 
03/08/2024 - 7:00am CST
Event ends: 
03/08/2024 - 8:00am CST
Mary Greeley Medical Center
1111 Duff Avenue
North Conference Room
Ames, IA 50010
United States

Accreditation Statements

  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.


No ineligible company provided financial support for this continuing education activity. 


Everyone in a position to control the content of this educational activity will disclose to the CME provider and attendees all relevant financial relationships with any commercial interest. The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. Firms providing financial support did not have input in these areas.


The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. The content of this educational offering does not reflect the views of Des Moines University.

Available Credit

  • 1.00 AOA Category 2­A


Please login or Create an Account to take this course.